1. Home
  2. ASIX vs DBVT Comparison

ASIX vs DBVT Comparison

Compare ASIX & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdvanSix Inc.

ASIX

AdvanSix Inc.

HOLD

Current Price

$15.92

Market Cap

526.1M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$18.29

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIX
DBVT
Founded
2016
2002
Country
United States
France
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
526.1M
508.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASIX
DBVT
Price
$15.92
$18.29
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$32.00
$24.46
AVG Volume (30 Days)
493.9K
452.4K
Earning Date
11-07-2025
10-28-2025
Dividend Yield
3.93%
N/A
EPS Growth
35.47
N/A
EPS
1.92
N/A
Revenue
$1,491,348,000.00
$5,502,000.00
Revenue This Year
$4.71
$1,768.71
Revenue Next Year
$4.59
$1,028.88
P/E Ratio
$8.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.10
$2.74
52 Week High
$32.58
$21.50

Technical Indicators

Market Signals
Indicator
ASIX
DBVT
Relative Strength Index (RSI) 46.97 69.42
Support Level $15.20 $17.86
Resistance Level $17.29 $21.50
Average True Range (ATR) 0.59 1.22
MACD 0.26 0.63
Stochastic Oscillator 48.46 66.53

Price Performance

Historical Comparison
ASIX
DBVT

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: